greeksoup/ stock research

Repligen (RGEN) Q4 FY2025 earnings: revenue $198 million, up 18.1% on the year

Repligen Corp. (RGEN) reported revenue of $198 million for Q4 FY2025, the quarter ended 31 December 2025, up 18.1% on the same quarter a year earlier. Net income was $13 million, and diluted earnings per share $0.23. The figures are the company's own, from the 10-K it filed with the SEC on 26 February 2026.

Revenue$198 millionup 18.1%
Net income$13 million
Diluted EPS$0.23
QuarterQ4 FY2025ended 31 December 2025

The quarter, against the one before and a year earlier

LineQ4 FY2025Q3 FY2025Q4 FY2024Change on the year
Revenue198189168+18.1%
Cost of revenue94.188.3129-26.9%
Gross profit10410138.8+167.3%
Gross margin52.5%53.2%23.2%
Research and development13.114.211.7+12.4%
Selling, general and administrative74.473.760.6+22.7%
Operating income17.916.8-36.5n/a
Operating margin9.0%8.9%-21.8%
Interest expense5.55.45.5+0.6%
Pre-tax income19.117.1-38.6n/a
Income tax5.82.2-4.7n/a
Effective tax rate30.5%12.9%n/a
Net income13.314.9-33.9n/a
Net margin6.7%7.9%-20.2%
Diluted EPS$0.23$0.26-$0.60n/a
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed.

Cash flow and capital returned

LineQ4 FY2025Q3 FY2025Q4 FY2024Change on the year
Operating cash flow25.748.139.2-34.4%
Capital expenditure8.24.75.5+47.2%
Free cash flow17.643.433.6-47.8%
Free cash flow margin8.9%23.0%20.1%
Cash from investing-209-7.8-64.8n/a
Cash from financing0.2-0.21.4-86.5%
Depreciation and amortisation20.020.018.4+8.6%
Share-based compensation8.09.0n/an/a
Diluted shares, weighted57m57m56m+1.1%
Shares outstanding at period end56m56m56m+0.4%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

LineQ4 FY2025Q3 FY2025Q4 FY2024Change on the year
Shareholders' equity2,1062,0831,973+6.8%
Debt542538526+3.2%
Operating lease liabilities126132146-13.3%
Other liabilities175171186-5.7%
Total liabilities and equity2,9502,9242,830+4.2%
Fixed assets187189198-5.6%
Goodwill1,1141,1131,031+8.1%
Intangible assets386395398-3.0%
Investments202n/a0.0n/a
Cash and equivalents566749757-25.3%
Receivables159149134+18.2%
Inventory170160143+19.2%
Other assets166169169-1.6%
Total assets2,9502,9242,830+4.2%

Quarterly results, the last 12 quarters

Q3 FY2023 †Q4 FY2023 * †Q1 FY2024 †Q2 FY2024 †Q3 FY2024Q4 FY2024 * †Q1 FY2025 †Q2 FY2025 †Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026
Revenue141167153159155168169182189198194204
Cost of revenue10588.176.477.377.412977.889.488.394.186.094.1
Gross profit36.678.576.881.577.538.891.493.0101104108110
Gross margin26%47%50%51%50%23%54%51%53%52%56%54%
R&D10.610.311.210.69.711.712.114.014.213.114.514.4
SG&A55.657.661.765.575.660.670.770.973.774.476.576.6
Operating income4.79.93.85.5-7.8-36.56.613.916.817.915.914.0
Operating margin3%6%2%3%-5%-22%4%8%9%9%8%7%
Interest expense0.31.14.95.05.15.55.25.45.45.55.65.7
Pre-tax income11.41.93.79.0-1.1-38.67.918.217.119.11.814.2
Tax rate-49%982%11%37%n/an/a27%18%13%30%-370%65%
Net income16.9-16.43.35.7-0.7-33.95.814.914.913.38.35.0
Net margin12%-10%2%4%-0%-20%3%8%8%7%4%2%
Diluted EPS$0.32-$0.46$0.04$0.06-$0.01-$0.60$0.10$0.26$0.26$0.23$0.15$0.09
Operating cash flow39.229.144.742.249.339.215.028.648.125.728.332.8
Capital expenditure8.411.18.34.87.05.53.67.14.78.24.75.3
Free cash flow30.818.036.437.442.333.611.421.543.417.623.627.4
Shares outstanding56m56m56m56m56m56m56m56m56m56m56m56m
Filing10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-K for the period ended 31 December 2025, filed 26 February 2026, accession 0001193125-26-076528: the filing on EDGAR. All of Repligen Corp.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install